BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10360173)

  • 1. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion.
    Pelengaris S; Littlewood T; Khan M; Elia G; Evan G
    Mol Cell; 1999 May; 3(5):565-77. PubMed ID: 10360173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Id2 is dispensable for Myc-induced epidermal neoplasia.
    Murphy DJ; Swigart LB; Israel MA; Evan GI
    Mol Cell Biol; 2004 Mar; 24(5):2083-90. PubMed ID: 14966287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia.
    Flores I; Murphy DJ; Swigart LB; Knies U; Evan GI
    Oncogene; 2004 Aug; 23(35):5923-30. PubMed ID: 15208685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of c-Myc in the skin affects the hair growth cycle and causes an enlargement of the sebaceous gland.
    Bull JJ; Pelengaris S; Hendrix S; Chronnell CM; Khan M; Philpott MP
    Br J Dermatol; 2005 Jun; 152(6):1125-33. PubMed ID: 15948972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omomyc expression in skin prevents Myc-induced papillomatosis.
    Soucek L; Nasi S; Evan GI
    Cell Death Differ; 2004 Sep; 11(9):1038-45. PubMed ID: 15143346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism.
    Knies-Bamforth UE; Fox SB; Poulsom R; Evan GI; Harris AL
    Cancer Res; 2004 Sep; 64(18):6563-70. PubMed ID: 15374969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny.
    Arnold I; Watt FM
    Curr Biol; 2001 Apr; 11(8):558-68. PubMed ID: 11369200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.
    Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML
    Mol Cell Biol; 2004 Sep; 24(17):7538-47. PubMed ID: 15314163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesis.
    Hansen LA; Brown D; Virador V; Tanaka T; Andreola F; Strain K; Dancheck B; Riley R; Arbeit JM; De Luca LM; Kogan S; Yuspa SH
    Cancer Res; 2003 Sep; 63(17):5257-65. PubMed ID: 14500356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of myc and telomerase interactions in vivo.
    Flores I; Evan G; Blasco MA
    Mol Cell Biol; 2006 Aug; 26(16):6130-8. PubMed ID: 16880523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.
    Pelengaris S; Khan M; Evan GI
    Cell; 2002 May; 109(3):321-34. PubMed ID: 12015982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
    Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
    Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC in mammalian epidermis: how can an oncogene stimulate differentiation?
    Watt FM; Frye M; Benitah SA
    Nat Rev Cancer; 2008 Mar; 8(3):234-42. PubMed ID: 18292777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
    Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis.
    Waikel RL; Wang XJ; Roop DR
    Oncogene; 1999 Aug; 18(34):4870-8. PubMed ID: 10490820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and role of c-Myc in mouse hair follicle morphogenesis and cycling.
    Wang N; Yang T; Li J; Lei M; Shi J; Qiu W; Lian X
    Acta Histochem; 2012 May; 114(3):199-206. PubMed ID: 21621827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of the transcription factor MafB in basal keratinocytes induces hyperproliferation and perturbs epidermal homeostasis.
    Miyai M; Tsunekage Y; Saito M; Kohno K; Takahashi K; Kataoka K
    Exp Dermatol; 2017 Nov; 26(11):1039-1045. PubMed ID: 28418611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc.
    Sumi T; Tsuneyoshi N; Nakatsuji N; Suemori H
    Oncogene; 2007 Aug; 26(38):5564-76. PubMed ID: 17369859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions.
    Hobbs RM; Silva-Vargas V; Groves R; Watt FM
    J Invest Dermatol; 2004 Sep; 123(3):503-15. PubMed ID: 15304090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.